Mller TD, Finan B, Clemmensen C, DiMarchi RD, Tschp MH
Schedule a wellness consultation to discuss your goals and explore personalized treatment options
10.2 Communicating benefits, limits, and safety boundaries Within the current evidence and regulatory framework, GLP-1RA management should be proceduralized using explicit entry points, target goals, and exit rules to minimize uncertainty and risk spillover: The triple-question pre-prescription assessment: before prescribing, clinicians should systematically address three questions: (i) What is the patients metabolic risk tier (BMI/IR, MASLD, glycemic status, etc.)
Additionally, the box warns not to use Ozempic if you or anyone in your family has ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Since tirzepatide is a subcutaneous injection, you need the tip to sit in the fatty layer beneath the skin but above the muscle